Trailing Twelve Months Revenue Growth: Aprea Therapeutics (APRE)

Public company logo of Aprea Therapeutics Inc. (APRE)

How does a biotech's minimal environmental footprint impact operational resilience? Aprea Therapeutics (APRE) minimizes supply risks through the complete outsourcing of production to certified CMOs in the US. Annual revenue growth from sales over a rolling period is derived from GURU.Markets data on this chart, where -99.10 captures the value of this parameter, confirming the success of the development of DNA repair-based targeted therapy.

Aprea Therapeutics, Inc. (APRE): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Aprea Therapeutics, Inc. - analytical breakdowns and key metrics (APRE)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:aprea.com
Brand item of aprea.com

This indicator determines the pace of business expansion by measuring the percentage change in revenue over the last 12 months relative to the same period last year. By analyzing the trailing 12-month (TTM) sales dynamics on GURU.Markets, an investor assesses the life cycle stage of Aprea Therapeutics (APRE), where management transparency in drug development allows one to distinguish a temporary stagnation from the systemic decline of the company.

Who Aprea Therapeutics competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CTXR: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) CLRB|Sales Growth YoY (TTM) BioLineRx Corporation (BLRX)|Sales Growth YoY (Last Twelve Months) Can-Fite BioPharma, Ltd. CANF|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)